🇧🇪 Short selling in Belgium, Q1 2023

From 2 Jan 2023 to 31 Mar 2023, 17 Belgium companies carried disclosed short positions. The quarter's highest single reading was COLRUYT at 3.20% on 5 Jan 2023. 1 company appeared in the data for the first time. 2 left it. Figures are disclosed positions from official FSMA data.

← Q4 2022 Q2 2023 →

Cite this page

Plain

Short position data for Short selling in Belgium, Q1 2023: FSMA, compiled by howshorted.com, position date 31 Mar 2023. https://howshorted.com/be/review/2023-q1/

Wikipedia

<ref>{{cite web |title=Short selling in Belgium, Q1 2023 short position data |url=https://howshorted.com/be/review/2023-q1/ |website=HowShorted |publisher=howshorted.com (data: FSMA) |date=2023-03-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-short-selling-in-belgium-q1-2023-2023-03-31,
  title        = {Short selling in Belgium, Q1 2023 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/be/review/2023-q1/}},
  note         = {Data: FSMA, position date 31 Mar 2023; accessed 2026-10-13},
  year         = {2023}
}

Biggest rises of the quarter

BIOCARTIS+0.40pp to 0.90%
COFINIMMO+0.10pp to 0.60%
UMICORE+0.08pp to 0.89%

Biggest falls of the quarter

COLRUYT−2.51pp to 0.59%
CP INVEST−1.06pp to 0.73%
PROXIMUS−0.73pp to 0.51%
SOLVAY−0.62pp to 1.00%
MITHRA PHARMACEUTICALS−0.09pp to 0.50%

Changes compare each company's last figure of the quarter with its first; companies with a single publication day in the quarter are counted but not ranked. Where disclosure thresholds apply the figures are floors, not a census. Nothing here is investment advice.